Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Holding IART?
Track your performance easily
Earnings Data
Report Date
Feb 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.85Last Year’s EPS
$0.89Same Quarter Last Year
Moderate Sell
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 04, 2024
|% Change Since: 13.07%
|Next Earnings Date:Feb 19, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted a mix of positive developments, such as a promising leadership transition and strong demand in key segments, against significant challenges like revenue decline, supply chain issues, and reduced margins. The Acclarent acquisition's success was a bright spot, but overall, the company faces ongoing operational difficulties and compliance hurdles.Company Guidance
During Integra LifeSciences' Q3 2024 earnings call, the company provided updated guidance reflecting ongoing supply challenges and the impact of their compliance master plan. The full-year revenue forecast was tightened to a range of $1.609 billion to $1.619 billion, with an expected adjusted EPS between $2.41 and $2.49. Organic revenue growth for the quarter decreased by 8.6% year-over-year, with specific declines in Codman Specialty Surgical (down 10.7%) and Tissue Technologies (down 3.7%). While the company's adjusted EBITDA margins were down to 16.2%, they anticipate a sequential revenue increase in Q4 driven by resolving most shipping holds and production improvements for Integra Skin. The compliance master plan will continue through 2025, with investments in facility and equipment upgrades aimed at enhancing quality, resilience, and capacity. Despite these challenges, Integra remains committed to addressing gaps in their quality management systems and ensuring supply meets demand, with a focus on future growth and operational improvements.Leadership Transition and New CEO Appointment
Mojdeh Poul will join as Integra's next President and CEO in January 2024, bringing extensive experience from 3M, Medtronic, and Boston Scientific.
Acclarent Acquisition Exceeding Expectations
The integration of Acclarent has outperformed expectations, generating approximately $30 million in Q3 revenue, with high single-digit growth anticipated.
Strong Demand in Neurosurgery and ENT Segments
Despite supply challenges, there was significant demand for Neurosurgery products and 5.3% organic growth in the ENT business.
Braintree Facility Progress
Construction of the Braintree facility is nearly complete, and equipment installation has begun, with production expected to resume in the first half of 2026.
---
IART Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
IART Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 04, 2024 | $19.28 | $24.12 | +25.10% |
| Jul 29, 2024 | $31.43 | $25.42 | -19.12% |
| May 06, 2024 | $28.89 | $23.14 | -19.90% |
| Feb 28, 2024 | $44.27 | $38.67 | -12.65% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Integra Lifesciences Holdings Corp. (IART) report earnings?
Integra Lifesciences Holdings Corp. (IART) is schdueled to report earning on Feb 19, 2025, TBA Not Confirmed.
What is Integra Lifesciences Holdings Corp. (IART) earnings time?
Integra Lifesciences Holdings Corp. (IART) earnings time is at Feb 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is IART EPS forecast?
IART EPS forecast for the fiscal quarter 2024 (Q4) is $0.85.
---